missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ MCDB 131 Medium, no glutamine

Click to view available options
Quantity:
500 mL
Unit Size:
500mL
Description
MCDB 131 Medium was originally developed by Knedler and Ham as reduced serum-supplemented medium for the culture of human microvascular endothelial cells (HUVEC). MCDB 131 Medium is also used with other cell types, including human omental microvascular cells, hepatocytes, myocytes, and smooth muscle cells.
Using MCDB 131
MCDB 131 Medium contains many components not found in traditional basal media, such as trace elements, putrescine, adenine, thymidine, and higher levels of some amino acids and vitamins. These additions allow the medium to be supplemented with very low levels of serum or defined components. MCDB 131 Medium contains no proteins or growth factors, and is often supplemented with EGF, hydrocortisone, glutamine, and low levels of Fetal Bovine Serum (FBS). The FBS concentration must be optimized for each cell type. MCDB 131 Medium uses a sodium bicarbonate buffer system (1.176 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.
Dual-site cGMP manufacturing
For supply chain continuity, we manufacture MCDB 131 at two separate facilities, located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP-manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.
Using MCDB 131
MCDB 131 Medium contains many components not found in traditional basal media, such as trace elements, putrescine, adenine, thymidine, and higher levels of some amino acids and vitamins. These additions allow the medium to be supplemented with very low levels of serum or defined components. MCDB 131 Medium contains no proteins or growth factors, and is often supplemented with EGF, hydrocortisone, glutamine, and low levels of Fetal Bovine Serum (FBS). The FBS concentration must be optimized for each cell type. MCDB 131 Medium uses a sodium bicarbonate buffer system (1.176 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.
Dual-site cGMP manufacturing
For supply chain continuity, we manufacture MCDB 131 at two separate facilities, located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP-manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.
Greener Choice Claims
- Environmental benefits include:
- Renewable Materials
- Recycled Content
- Source Reduction
- Recyclable

Specifications
Specifications
Cell Type | Human Microvascular Endothelial Cells (HMVEC), Human Omental Microvascular Cells, Hepatocytes, Myocytes, Smooth Muscle Cells |
Concentration | 1 X |
Form | Liquid |
Product Type | MCDB 131 Medium |
Sterility | Sterile-filtered |
With Additives | Low Glucose, Phenol Red, Sodium Pyruvate |
Without Additives | No Glutamine, No HEPES |
Product Line | Gibco™ |
Quantity | 500 mL |
Shipping Condition | Room Temperature |
Show More |
Documents
Scientific Resources
Brochures
Brochure: 3D cell culture product selection guide for organoids and spheroids
File size: 625.2 kB
Brochure: One cell biology—Our cell biology portfolio at a glance
File size: 2.1 MB
Certificates
Certificates
A lot number is required to show results for certificates. To find your lot number on previous orders use our order status area.
5 results found
Lot Number | Certificate Type | Date | Product Code |
---|---|---|---|
2473958 | Certificate of Analysis | 29/01/2025 | 10372019 |
2555061 | Certificate of Analysis | 29/01/2025 | 10372019 |
2445655 | Certificate of Analysis | 29/01/2025 | 10372019 |
2451109 | Certificate of Analysis | 29/01/2025 | 10372019 |
2428782 | Certificate of Analysis | 29/01/2025 | 10372019 |
For Research Use Only. Not for use in diagnostic procedures.
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Gibco™ MCDB 131 Medium, no glutamine >
Spot an opportunity for improvement?Share a Content Correction